PE ratio relative to earnings growth — is the valuation justified?
—
PEG Ratio
Negative EPS growth — PEG not meaningful when earnings are declining
—
Growth Rate Source
Good Data Quality5-Year EPS CAGR
Current Price
$7.82
TTM EPS
$0.59
P/E Ratio
13.25
Growth Rate
-8.1%
5-Year EPS CAGR
Sector
Healthcare
Biotechnology
Calculated
8/28/2026
12:49:37 PM
PEG Ratio Unavailable
Negative Growth — PEG not meaningful
Peer Comparison
Sample Size
3 peers
Industry Median PEG
5.64
25th Percentile
2.76
75th Percentile
9.25
Symbol
Company
PEG
P/E
Growth
vs GRFS
BMY
BRISTOL MYERS SQUIBB CO
2.76
14.7
5.3%
—
MRK
Merck & Co., Inc.
5.64
119.6
21.2%
—
AMGN
AMGEN INC
9.25
27.2
2.9%
—
How to Interpret PEG Ratio
PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.
PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."
PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.
Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.
